Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

Clinical trial NCT00776230 · COMPLETED

Trial details

NCT number: NCT00776230
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2008-09-01
Primary completion: 2010-06-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.